[Effect of ethyl-p-nitrophenyl phenylphosphonothiate (EPN) on tryptophan pyrrolase activity in relation to miosis and change in serum cholinesterase activities].
D000311:Adrenal Glands / Q000502:physiology; D000496:Alloxan / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002802:Cholinesterases / Q000097:blood*; D003864:Depression, Chemical; D004106:Dilatation; D004878:Ergotamine / Q000494:pharmacology; D007306:Insecticides / Q000494:pharmacology*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009578:Nitrobenzenes / Q000494:pharmacology; D063065:Organophosphonates / Q000494:pharmacology*; D010758:Phosphorus / Q000494:pharmacology*; D011220:Pralidoxime Compounds / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects*; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology; D014366:Tryptophan Oxygenase / Q000378:metabolism*
D007306:Insecticides; D008996:Monoamine Oxidase Inhibitors; D009578:Nitrobenzenes; D063065:Organophosphonates; D011220:Pralidoxime Compounds; D013565:Sympatholytics; D010758:Phosphorus; D000496:Alloxan; D001285:Atropine; D011433:Propranolol; D014366:Tryptophan Oxygenase; D002802:Cholinesterases; D004878:Ergotamine